West Point and Cannabix Breathalyzer Inc. Finalize Definitive Agreement
June 16, 2014
Vancouver, British Columbia, June 16, 2014: West Point Resources Inc. (TSX Venture: WPO) (the “Company”) is pleased to announce it has finalized a definitive agreement with Cannabix Breathalyzer Inc to license the North American Rights to the Cannabix Marijuana Breathalyzer. The Company also reports that it has received conditional approval from the Canadian Securities Exchange (CSE) for its listing application. West Point is also currently completing a concurrent private placement financing.
Mr. Kal Malhi and Dr. Raj Attariwala from Cannabix Breathalyzer Inc will be joining West Point’s management team and will guide the development of the marijuana breathalyzer system. Dr. Bruce Goldberger from the University of Florida is also joining as a Senior Advisor.
West Point’s drug-impairment recognition system is starting to receive local media attention and has recently been featured on CTV news, The Province, and The Delta Optimist. Several other local and international media outlets have expressed interest in providing media coverage for the marijuana breathalyzer product being developed by West Point and interviews will be scheduled over the coming weeks.
We seek Safe Harbor.
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.